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Background: A set of 1181 E. coli strains of human fecal origin isolated in the South Moravia region of the Czech
Republic was collected during the years 2007–2010. Altogether, 17 virulence determinants and 31 bacteriocin-
encoding genes were tested in each of them.
Results: The occurrence of bacteriocin-encoding genes was found to be positively correlated with the occurrence
of E. coli virulence factors. Based on the presence of virulence factors and their combinations, E. coli strains were
classified as non-pathogenic E. coli (n = 399), diarrhea-associated E. coli (n = 179) and ExPEC strains (n = 603).
Non-pathogenic and diarrhea-associated E. coli strains had a low frequency of bacteriocinogeny (32.6% and 36.9%,
respectively). ExPEC strains encoding S-fimbriae (sfa), P-fimbriae (pap) and having genes for aerobactin biosynthesis
(aer, iucC), α-hemolysis (α-hly) and cytotoxic necrosis factor (cnf1) were often bacteriocinogenic (73.8%), had a high
prevalence of bacteriocin multi-producers and showed a higher frequency of genes encoding microcins H47, M, V,
B17 and colicins E1, Ia and S4.
Conclusions: The occurrence of bacteriocin-encoding genes and ExPEC virulence determinants correlate positively
in E. coli strains of human fecal origin. Bacteriocin synthesis appears to modulate the ability of E. coli strains to reside
in the human intestine and/or the virulence of the corresponding strains.
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The endogenous human gut microbiome has several im-
portant functions including nourishment, the training
of innate immunity and the regulation of epithelial de-
velopment [1]. Although the Escherichia coli population
represents a rather small portion of the intestinal bac-
terial microflora, E. coli nonetheless occupy an import-
ant niche with regard to their close proximity to
intestinal epithelium, wherein they utilize available oxy-
gen and facilitate anaerobic growth [2]. Intestinal micro-
flora also prevent the growth of pathogenic bacteria,
either by competing for nutrient sources, or through* Correspondence: dsmajs@med.muni.cz
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article, unless otherwise stated.direct bacterial antagonism mediated by bacteriocins
and bacteriophages [3].
E. coli is a highly diverse species with respect to its
gene content, phenotype and virulence [4]. Based on
different virulence factors, E. coli strains can be classified
into three main groups: commensal, intestinal patho-
genic and extraintestinal pathogenic E. coli (ExPEC) [5].
Commensal strains are commonly considered to be non-
pathogenic. It has been shown that intestinal and extra-
intestinal pathogenic E. coli strains can develop from
commensal strains by acquisition of virulence factors
[6,7].
Intestinal pathogenic (diarrhea-associated) E. coli is a
typical mucosal pathogen which uses different patho-
genic strategies including invasion of host cells (enter-
oinvasive E. coli, EIEC), production of enterotoxins
(enterotoxigenic E. coli, ETEC) and production of Shiga-tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Enteropathogenic E. coli (EPEC) strains cause attaching-
and-effacing (A/E) lesions and harbor the EAF plasmid
[8]. Diffuse-adherent strains of E. coli (DAEC) are
characterized by continuous adherence to eukaryotic
cells mediated by afimbrial adhesins [9], while entero-
aggregative (EAggEC) strains produce an aggregative
adherence (AA) pattern [10] when adhering to HEp-2
cells.
ExPEC strains carry different combinations of viru-
lence factors. Johnson et al. (2003) defined ExPEC
strains as those possessing 2 or more of the following
virulence factors: P fimbriae, S/F1C fimbriae subunits,
Dr-antigen binding adhesins, aerobactin receptor and
group 2 capsule synthesis [11].
Another important characteristic of human E. coli
strains is production of bacteriocins. Colicins and micro-
cins are antimicrobial agents with a relatively narrow
spectrum of activity [12-14]. In general, microcins are
known to have a wider spectra of antibacterial activity
compared to colicins [14,15]. Colicin Js [16,17] is unique
in that it shares features of both colicins and microcins.
The ecological role and molecular evolution of bacterio-
cinogeny are less clear but synthesis of bacteriocins may
have both invasive and defensive functions in microbial
communities [18]. Bacteriocin production is a common
feature of many probiotic bacteria. For example, micro-
cins H47 and M are active substances produced by the
non-pathogenic, probiotic E. coli strain Nissle 1917 [19].
At the same time, several studies have shown an asso-
ciation between the production of some types of bacte-
riocins and pathogenic E. coli strains [20-23]. Previous
studies have found that genes encoding colicin E1, as
well as microcins H47, M, I47, E492 and V were associ-
ated with extraintestinal pathogenic E. coli strains
[20-23]. Colicin E1 is also known to have toxic effects
on eukaryotic cells and is considered to be a virulence
factor in UPEC strains [21,24,25]. Microcins H47 and M
are induced when iron is a limiting factor and are associ-
ated with competition for iron [22,26]. Synthesis of
microcin H47 and M could therefore be advantageous in
bacteremia of urinary tract origin [22,26].
Previously published studies have only provided partial
insight into the association between bacteriocin produc-
tion and bacterial virulence, as they were primarily fo-
cused upon UPEC strains and differed in the number of
detected bacteriocin and virulence genes. Azpiroz et al.
(2009) screened 5 microcin types in 125 UPEC strains
and 9 virulence factors [20], while Budič et al. (2011)
and Petkovšek et al. (2012) analyzed 14 virulence factors
(primarily those associated with urinary tract infections)
and 19 bacteriocin types in 105 UPEC strains [22,23].
Similarly, Abraham et al. (2012) analyzed 16 bacteriocin
types and 18 virulence factors in a collection of 159UPEC strains [27]. Together, these studies identified an
association between microcins (M, H47, V, B17 and L)
and several virulence genes [20,22,23,27]. Studies by
Gordon et al. (2005) and Gordon and O’Brien (2006)
focused on 266 fecal E. coli strains and identified an
association between strains encoding at least one microcin
type, and four genes involved in iron acquisition (from a
total of 29 tested virulence determinants) [26,28].
The main aim of our study was to test the association
between bacteriocin production and bacterial virulence
within a large collection of E. coli strains (n = 1181)
isolated from human gut microflora. In this study, new
associations between bacteriocin-encoding genes and
virulence determinants were found in human fecal
E. coli strains.
Results
Detection of virulence determinants and bacteriocin-
encoding genes
Altogether, 18 DNA determinants (pCVD432, α-hly,
afaI, aer, cnf1, sfa, pap, ial, lt, st, bfpA, eaeA, ipaH, iucC,
fimA and stx1, stx2 and ehly) encoding 17 different viru-
lence factors were tested in each of 1181 E. coli strains
(Additional file 1: Table S1). The vast majority of strains
(94.7%) possessed at least one virulence factor. The most
common virulence determinant was the fimA gene
(encoding fimbriae type I), which was detected in
87.9% of all strains.
Genes encoding 29 bacteriocin types including 24 coli-
cin types (A, B, D, E1-9, Ia, Ib, Js, K, L, M, N, S4, U, Y, 5
and 10) and 5 microcin types (B17, C7, J25, L and V)
were tested in each of 642 E. coli bacteriocin producer
strains. Further, the prevalence of chloroform sensitive
microcins H47 and M [19] was tested in each of the
1181 E. coli strains. The average prevalence of bacterio-
cinogeny in the set of 1181 E. coli strains was 54.4%
(Additional file 1: Table S1). In contrast to other bacteri-
ocin determinants, genes encoding colicins A, E4, E9
and L were not detected in any producer strain. Most of
bacteriocin producers were strains producing two or
more bacteriocin types (Additional file 1: Table S1).
Association between bacteriocin and virulence
determinants
We found that 28.6% of E. coli strains possessing no
virulence determinant (n = 63) produced bacteriocins
and 34% of the strains harboring one virulence deter-
minant (n = 377) produced bacteriocins. In addition,
58.2% of E. coli encoding two virulence determinants
(n = 220) had bacteriocin genes and 70.6% of the strains
with 3 to 7 virulence determinants (n = 521) were bacter-
iocinogenic (Figure 1).
A correspondence analysis (CA) was performed using
individual virulence determinants and bacteriocin-
Figure 1 Association between number of virulence factors encoded by E. coli strains and bacteriocin production. Frequency of
bacteriocinogeny in E. coli strains correlates with number of virulence factors coded by E. coli. The x axis represents the number of virulence
factors coded by E. coli strains (n represents the number of strains encoding the appropriate number of virulence factors) and the y axis shows
the frequency of bacteriocinogeny.
Figure 2 Correspondence analysis for bacteriocin types and virulence factors. Association between virulence factors (α-hly, afaI, aer, cnf1,
sfa, pap, pCVD432, ial, lt, st, bfpA, eaeA, ipaH, iucC, fimA, ehly) and bacteriocin types (B, D, E1, E2-9, Ia, Ib, Js, K, M, N, S4, U/Y, 5/10, mB17, mC7,
mH47, mJ25, mL, mM and mV) in 1181 E. coli strains. The x axis accounted for 51.06% of total inertia and the y axis for 24.02%. Please note the
close association between virulence determinants pap, sfa, cnf1 and α-hly and genes for microcins H47, M and L. Genes encoding aerobactin
synthesis plotted close to bacteriocin genes encoding microcins J25, V and B17 and colicins B, E1, 5/10, Ia, Ib, Js, M, K, N, S4 and D. Fisher’s exact
test was used to analyze the degree of association among bacteriocin types and virulence factors; statistically significant results for different
virulence factors and bacteriocin types are indicated by asterisks (α-hly, cnf1, sfa, pap – mH47 and mM; iucC, aer – E1, Ia, S4 and mV; afaI,
eaeA/bfpA, pCVD432, nonVF – bacteriocin non-producers).
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dimensional representation, Fisher’s exact test was used
to analyze the association between bacteriocin types and
virulence determinants. Genes encoding aerobactin syn-
thesis were (aer, iucC) were significantly associated with
genes for microcin V (p < 0.01) and with genes encoding
colicins E1 (p < 0.01), Ia (p < 0.01) and S4 (p = 0.01). The
α-hly, cnf1, sfa and pap virulence determinants were
plotted together and were associated with genes for
microcins H47 (p < 0.01) and M (p < 0.01). Bacteriocin
non-producers were associated with afaI (p < 0.01),
eaeA/bfpA (p < 0.01), pCVD432 (p = 0.03) and with
strains in which virulence determinants were not detected
(p < 0.01) (Figure 2).
Association between bacteriocin-encoding genes and E.
coli pathotypes
Based on the presence of virulence factors, E. coli strains
were divided into three groups: (1) non-pathogenic
(commensal, non enterovirulent, nonEVEC) E. coli (n =
399), (2) diarrhea-associated E. coli (EAggEC, ETEC,
EIEC, EPEC and DAEC; n = 179) and (3) fecal E. coli
with characteristics similar to ExPEC, denoted ExPEC in
this study (n = 603) (Table 1). Non-pathogenic E. coliTable 1 Occurrence of virulence factors in E. coli pathotypes
Virulence factors
Non-pathogen
n = 399 (%)
Aggregative adherence plasmid pCVD432 -
Invasive associated locus ial -
Heat-stable enterotoxin st -
Heat-labile enterotoxin lt -
Intimin eaeA -
Bundle-forming fimbriae bfpA -
Invasion plasmid H ipaH -
Aerobactin synthesis aer -
Fimbriae type 1 fimA 336 (84.2)
α-hemolysin α-hly -
Afimbrial adhesin afaI -
Aerobactin synthesis iucC -
Cytotoxic necrotizing factor cnf1 -
S-fimbriae sfa -
P-fimbriae pap -
Shiga-toxin 1 stx1 -
Shiga-toxin 2 stx2 -
Enterohemolysin ehly -
*E. coli strains with no detected genes for virulence factors or those possessing only
**EAggEC - pCVD432 (aggregative adherence plasmid); ETEC - lt/st (heat-labile and
plasmid H); EPEC – bfpA/eaeA (bundle-forming fimbriae/intimin); EHEC (stx1/stx2/ehl
***E. coli strains which contain different virulence factors (except those that are typ
E. coli strains (α-hemolysin, P-fimbriae, S-fimbriae, cytotoxic necrosis factor, aerobacwere defined as those with no detected genes for
virulence factors or those that only had the gene for
fimbriae type I (fimA gene). Diarrhea-associated E. coli
strains encoded virulence factors typical for each of the
diarrhea-associated pathotypes including EAggEC
(pCVD432), ETEC (lt/st), EIEC (ial/ipaH), EPEC (eaeA/
bfpA), EHEC (stx1/stx2/ehly) and DAEC (afaI) strains.
All other strains containing genes for different virulence
factors (e.g. α-hemolysin, P-fimbriae, S-fimbriae, cyto-
toxic necrosis factor, aerobactin synthesis) and combina-
tions thereof were classified as ExPEC. The results of the
correspondence analysis of individual virulence determi-
nants and bacteriocin genes (Figure 2) showed that a
majority of bacteriocin genes overlap with virulence
determinants belonging to ExPEC strains.
The occurrence of bacteriocinogeny (i.e. occurrence of
at least one bacteriocin-encoding gene) in nonEVEC
strains (32.6%) and in diarrhea-associated E. coli strains
(36.9%) was significantly lower than among ExPEC
(73.8%; p < 0.01) (Table 2). In addition, a similar fre-
quency of bacteriocin types was also found in both
groups of nonEVEC and diarrhea-associated E. coli.
Among nonEVEC strains, those with a single bacteriocin
gene were most common, while ExPEC strains morePathotype
ic E. coli* Diarrhea-associated E. coli** ExPEC***








68 (38.0) 342 (56.7)
149 (83.2) 553 (91.7)
3 (1.7) 88 (14.6)
78 (43.6) -
80 (44.7) 396 (65.7)
1 (0.6) 43 (7.1)
6 (3.4) 227 (37.6)




gene for fimbriae type I (fimA gene).
heat-stable enterotoxin); EIEC - ial/ipaH (invasion associated locus/invasion
y); DAEC – afaI (afimbrial adhesin I).
ical for previously described diarrhea-associated E. coli) typical for extraintestinal
tin synthesis).
Table 2 Occurrence of bacteriocinogeny and bacteriocin types among E. coli strains
Bacteriocinogeny Pathotype Statistics*
1. Non-pathogenic E. coli 2. Diarrhea-associated E. coli 3. ExPEC 1 x 2 1 x 3 2 x 3
n = 399 (%) n = 179 (%) n = 603 (%) p p p
Bacteriocinogenic strains 130 (32.6) 66 (36.9) 445 (73.8) -** < 0.01 < 0.01
Bacteriocin types
mV 18 (4.5) 18 (10.1) 152 (25.2) 0.04 < 0.01 < 0.01
mM 17 (4.3) 7 (3.9) 123 (20.4) - < 0.01 < 0.01
mH47 28 (7.0) 14 (7.8) 165 (27.4) - < 0.01 < 0.01
mB17 10 (2.5) 8 (4.5) 57 (9.5) - < 0.01 -
Ia 53 (13.3) 23 (12.8) 125 (20.7) - < 0.01 -
E1 19 (4.8) 15 (8.4) 94 (15.6) - < 0.01 0.04
S4 - - 11 (1.8) - 0.01 -
Bacteriocin producer strains
Mono-producers*** 63 (48.5) 23 (34.8) 141 (31.7) - < 0.01 -
Ia 23 (17.7) 3 (4.5) 18 (4.0) 0.04 < 0.01 -
Double-producers**** 44 (33.8) 25 (37.9) 161 (36.2) - - -
mH47, mM 5 (3.8) 4 (6.1) 50 (11.2) - 0.03 -
Multi-producers***** 21 (16.2) 15 (22.7) 139 (31.2) - < 0.01 -
*Fisher’s exact test with Bonferroni correction.
**not statistically significant.
***producers of one bacteriocin type.
****producers of two bacteriocin types.
*****producers of three and more bacteriocin types.
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strain. Compared to nonEVEC and diarrhea-associated
strains, ExPEC had higher frequencies of genes encoding
microcins V, H47, M (p < 0.01 against both nonEVEC
and diarrhea-associated strains) and gene encoding
colicin E1 (p < 0.01 against nonEVEC, p = 0.04 against
diarrhea-associated strains). In addition, compared to
nonEVEC strains, ExPEC had higher frequencies of
genes encoding microcin B17 (9.5%; p < 0.01) and colicins
Ia (20.7%; p < 0.01), E1 (15.6%; p < 0.01) and S4 (1.8%;
p = 0.01).
Discussion
In this study, the average prevalence of bacteriocino-
genic E. coli strains isolated from fecal microflora was
54.4%. This value is close to the upper range limit seen
in previous studies, where the prevalence of bacterioci-
nogenic E. coli strains varied from 25 to 55%
[15,21,26,27,29-31]. However, these studies differed in a
number of important ways including cultivation condi-
tions and indicator bacteria used for detection of bac-
teriocin production and/or in the number of detected
bacteriocin genes. Older studies on the prevalence of
bacteriocinogeny in fecal E. coli strains only focused on
the identification of colicin production [30,32]. While
Šmarda and Obdržálek (2001) used five different indica-
tor strains to detect colicin production in the fecal E.coli strain 1043 [32], Achtman et al. (1983) used 2 indi-
cator strains for the detection of colicin producers in a
sample of 234 fecal E. coli strains [30]. More recently,
Gordon and O’Brien (2006) used PCR with 19 bacteri-
ocin genes to screen 266 fecal E. coli strains (38% of
which were bacteriocinogenic) [26], and Šmajs et al.
(2010) detected 29 bacteriocin types in 411 fecal E. coli
strains (55% of which were bacteriocin-encoding strains)
[21].
Our results have revealed that the frequency of bacter-
iocinogeny in E. coli strains positively correlates with the
detected number of virulence determinants. Bacterioci-
nogeny increased by as much as 75–80% depending on
the number of encoded virulence factors. To our know-
ledge, this is the first time that the correlation between
bacteriocinogeny frequency and the number of encoded
virulence factors has been shown. This finding suggests
that at least some bacteriocin-encoding genes should be
considered as factors which increase the virulence of
E. coli strains.
E. coli strains encoding only fimbriae type I did not
show differences in the frequency of bacteriocinogeny
compared to strains without genes for virulence factors.
The role of fimbriae type I in development of human
infections is not clear. Although deletion of the fim gene
cluster from virulent E. coli strain O1:K1:H7 attenuated
virulence in the urinary tract infection (UTI) model [33];
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different sources was not found to correlate with the
ability to cause UTIs [34-39]. Several virulence factors,
typical for diarrhea-associated E. coli strains, including
pCVD432 (EAggEC), ial/ipaH (EIEC), eaeA/bfpA
(EPEC) and afaI (DAEC) were not found to be associ-
ated with bacteriocin genes. Bacteriocin producers there-
fore appear to be mainly associated with ExPEC
virulence factors (E. coli strains containing combinations
of sfa, pap, aer, iucC, cnf1, α-hly determinants). The
occurrence of these virulence factors were associated
with both chromosomally (microcins H47 and M) and
plasmid encoded colicin (E1, Ia and S4) and microcin
types (B17, V).
Presently, several bacteriocins including colicin E1,
and microcins H47, I47, E492, M, and V are considered
virulence factors in extraintestinal pathogenic E. coli
strains [20-23]. Azpiroz et al. [20] and Budič et al. [22]
found an association between production of microcins
H47, I47, E492, M, and V and the distribution of viru-
lence factors (i.e. hlyA, cnf1, usp, iroN, iroCD, fyuA,
papC, papG and tcpC) in uropathogenic strains of E.
coli; from these results they assumed that production of
these bacteriocin types could contribute to development
of bacteraemia. Although different sets of virulence
determinants and bacteriocin genes were used in these
studies, our findings match with these observations.
We also found these associations between bacteriocin
production and ExPEC virulence determinants among
human fecal E. coli isolates. Moreover, we have found
new associations between 3 bacteriocin types (microcin
B17, colicins Ia and S4) and the ExPEC virulence charac-
teristics of human fecal E. coli strains. Given that colicin
Ia and microcin B17 are known to be encoded on rela-
tively large plasmids, it is possible that the association
with more virulent strains is due to other genes being
harbored on these plasmids, and not by colicin synthesis
itself. However, colicin S4 was found to be encoded on a
small plasmid (7.4 kb) [40] that was similar to the colicin
E1-encoding plasmid (6 kb) [21]. Since these small plas-
mids do not encode virulence factors, colicin S4 appears
to be a potentially important virulence factor and/or an
important factor of resident E. coli strains.
The presence of virulence determinants (e.g. genes
encoding P-fimbriae, siderophore aerobactin, hemolysin
and expression of O antigens, which are typical for
ExPEC strains; and capsular types K1 and K5) are associ-
ated with resident E. coli strains [41-44]. At the same
time, ExPEC strains causing extraintestinal infections
like urinary tract infections and sepsis/meningitidis are
believed to originate from the gut microflora. Their
virulence determinants including adhesins (P-fimbriae,
S-fimbriae), toxins (e.g. hemolysin, cytotoxic necrotizing
factor) and siderophores (e.g. aerobactin) appear to beimportant for E. coli strains to survive in the extraintes-
tinal environment [45-47].
On the other hand, we found that diarrhea-associated
strains from our set of 1181 fecal E. coli had a lower
prevalence of bacteriocinogeny and a lower frequency of
several bacteriocin producers. In addition, no specific
bacteriocin types appear to be associated with virulence
determinants that are typical for these strains. Unlike
fecal strains which have the characteristics of ExPEC
strains, diarrhea-associated strains are not considered to
be resident human E. coli strains, which may explain the
lower prevalence of bacteriocin genes.
In summary, bacteriocin synthesis is linked to strains
with ExPEC characteristics and appears to increase the
ability of E. coli to reside in the human gut. Moreover, at
least several bacteriocin-encoding genes should be also
considered as factors which increase the virulence of
ExPEC strains.Conclusions
The frequency of bacteriocin-encoding genes was found
to be positively correlated with the frequency of E. coli
virulence determinants. E. coli with virulence character-
istics of ExPEC strains, i.e. strains encoding virulence
factors S-fimbriae (sfa), P-fimbriae (pap), cytotoxic ne-
crosis factor (cnf1), α-hemolysin (α-hly) and aerobactin
biosynthesis (aer, iucC) were more often found to harbor
genes encoding synthesis of microcins (H47, M, V and
B17) and colicins (E1, Ia and S4) than other tested E. coli
strains.Methods
Bacterial strains
E. coli strains were isolated from the intestinal micro-
flora of 1181 patients living in South Moravia, Czech
Republic. A set of 183 E. coli strains was isolated at St.
Anne's University Hospital, Brno, CZ, and 998 E. coli
strains at the University Hospital, Brno, CZ. E. coli
strains were isolated between July 2007 and April 2010.
565 E. coli strains were isolated from female patients
and 616 E. coli strains from males. All clinical samples
were collected after patients gave informed consent. For
children under the age of 18, consent was obtained from
parents. The study was approved by the ethics commit-
tee of the Faculty of Medicine, Masaryk University, Brno,
CZ. A single isolate of E. coli was collected from each
patient. Testing with ENTEROtest16 (Erba Lachema,
Czech Republic) was used for bacterial identification. In-
dicator strains used for screening of bacteriocin produc-
tion and the control bacteriocin producers used for PCR
detection of bacteriocin genes, were previously described
in detail [21].
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Bacteriocin production was detected using the method
described by Šmajs et al. (2010) [21]. Briefly, each of
1181 E. coli strains were simultaneously cultivated (37°C
for 48 hours) in parallel on four different agar plates con-
taining (i) TY (Trypton-yeast) agar (HiMedia, Mumbai,
India) (1.5%, w/v, solid agar), (ii) Difco™ Nutrient broth
(Difco Laboratories, Sparks, MD, USA), (iii) TY agar
supplemented with mitomycin C, and (iv) TY agar sup-
plemented with trypsin. Macrocolonies were then killed
using chloroform vapors and overlaid with a top TY
agar layer (0.7%, w/v, soft agar) containing 107 cells
from one of 6 indicator strains (E. coli K12-Row, E. coli
C6 (φ), E. coli 5 K, E. coli P400, E. coli S40 and Shigella
sonnei 17). The plates were subsequently incubated at
37°C for 24 hours and bacteriocin producers were
identified.PCR detection of genes encoding bacteriocins
Detection of the 24 colicin and 7 microcin genes was
carried out using the method described by Šmajs et al.
(2010) [21]. Briefly, genomic DNA was isolated using
DNAzol reagent (Invitrogen, Carlsbad, CA, USA) ac-
cording to the manufacturer’s protocol. Template DNA
was diluted 100-fold in sterile distilled water. All produ-
cer strains were tested, in parallel, using the colony PCR
method (one bacterial colony from each strain was
resuspended in 100 μl of sterile distilled water; then 1 μl
of this suspension was added to the PCR mix). PCR re-
actions were performed using the primers described by
Šmajs et al. (2010) [21]; for colicins E1, L and microcin
M additional primer pairs were used (Additional file 2:
Table S2). The following protocol was used for PCR
amplification: 94°C (2 minutes); 94°C (30 seconds), 60°C
(30 seconds), 72°C (1 minute), 30 cycles; 72°C (7 minutes).
For colony PCR, the initial step was 5 minutes. Micro-
cins H47 and M are sensitive to chloroform vapors
[19], therefore all 539 bacteriocin-nonproducing E. coli
strains were investigated using PCR with specific H47
and M primers. PCR products of sequentially related
bacteriocins (colicins E2-9, Ia-Ib, U-Y, 5–10) were veri-
fied using dideoxy terminator sequencing and amplifica-
tion primers. Sequence analysis was carried out using
Lasergene software (DNASTAR, Inc., Madison, WI,
USA).Screening for genes encoding virulence factors
All 1181 E. coli strains were screened for the presence of
genes for 17 different virulence factors (α-hly, afaI, aer,
cnf1, sfa, pap, pCVD432, ial, lt, st, bfpA, eaeA, ipaH,
iucC, fimA, stx1, stx2 and ehly). The primer pair se-
quences, PCR product lengths and PCR protocols used,
were previously described [48-55].Statistical analyses
For statistical analysis of the incidence of bacteriocins
and virulence factors, standard methods derived from the
binomial distribution, including the two-tailed Fisher’s
exact test corrected using the Bonferroni correction, were
used. STATISTICA software, version 8.0 (StatSoft, Tulsa,
OK, USA), was used for calculations. Distribution of
virulence factors and bacteriocin genes were determined
using Correspondence Analysis (CA) and STATISTICA
version 8.0.
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